Xerosis (Dry Skin) – Pipeline Review, H2 2012

Publisher Name :
Date:31-Oct-2012
No. of pages: 24
Inquire Before Buying

Xerosis (Dry Skin) – Pipeline Review, H2 2012

Summary

Global Markets Direct’s, ‘Xerosis (Dry Skin) – Pipeline Review, H2 2012′, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Xerosis (Dry Skin), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Xerosis (Dry Skin). Xerosis (Dry Skin) – Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Xerosis (Dry Skin).
- A review of the Xerosis (Dry Skin) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Xerosis (Dry Skin) pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Xerosis (Dry Skin).
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Xerosis (Dry Skin) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Xerosis (Dry Skin) – Pipeline Review, H2 2012

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Introduction 4
Global Markets Direct Report Coverage 4
Xerosis (Dry Skin) Overview 5
Therapeutics Development 6
An Overview of Pipeline Products for Xerosis (Dry Skin) 6
Xerosis (Dry Skin) Therapeutics under Development by Companies 8
Late Stage Products 9
Comparative Analysis 9
Discovery and Pre-Clinical Stage Products 10
Comparative Analysis 10
Xerosis (Dry Skin) Therapeutics - Products under Development by Companies 11
Companies Involved in Xerosis (Dry Skin) Therapeutics Development 12
Syntopix Group Plc 12
Pierre Fabre Medicament 13
Xerosis (Dry Skin) - Therapeutics Assessment 14
Assessment by Monotherapy Products 14
Assessment by Route of Administration 15
Drug Profiles 17
HO/04/08 - Drug Profile 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
V0034-CR01B - Drug Profile 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
Emollient-1 - Drug Profile 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Emollient-2 - Drug Profile 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Emollient-3 - Drug Profile 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Xerosis (Dry Skin) Therapeutics - Dormant Products 22
Appendix 23
Methodology 23
Coverage 23
Secondary Research 23
Primary Research 23
Expert Panel Validation 23
Contact Us 24
Disclaimer 24

List of Tables
Number of Products Under Development for Xerosis (Dry Skin), H2 2012 6
Products under Development for Xerosis (Dry Skin) - Comparative Analysis, H2 2012 7
Number of Products under Development by Companies, H2 2012 8
Comparative Analysis by Late Stage Development, H2 2012 9
Comparative Analysis by Discovery and Pre-Clinical Stage Development, H2 2012 10
Products under Development by Companies, H2 2012 11
Syntopix Group Plc, H2 2012 12
Pierre Fabre Medicament, H2 2012 13
Assessment by Monotherapy Products, H2 2012 14
Assessment by Stage and Route of Administration, H2 2012 16
Xerosis (Dry Skin) Therapeutics - Dormant Products 22

List of Figures
Number of Products under Development for Xerosis (Dry Skin), H2 2012 6
Products under Development for Xerosis (Dry Skin) - Comparative Analysis, H2 2012 7
Products under Development by Companies, H2 2012 8
Late Stage Products, H2 2012 9
Discovery and Pre-Clinical Stage Products, H2 2012 10
Assessment by Monotherapy Products, H2 2012 14
Assessment by Route of Administration, H2 2012 15
Assessment by Stage and Route of Administration, H2 2012 16

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Chronic Lymphocytic Leukemia (CLL) Treatment Market worth $3.3 billion by 2018
  • New Entrants to Boost Chronic Lymphocytic Leukemia Treatment Market Value to $3.3 Billion by 2018, says GlobalData. The introduction of several new drugs will accelerate growth in the Chronic Lymphocytic Leukemia (CLL) treatment market, from $1.4 billion in 2013 to …

  • Global Biosimilars Market to Grow at a CAGR of 8.3%, to reach $262 billion by 2019
  • Lucrative Biosimilars Space to Erode Biologics Market from 2019, says GlobalData The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected Compound Annual Growth Rate (CAGR) of 8.3%, taking …

  • Saudi Pharmaceutical Market worth $5.9 billion by 2020
  • A high burden of chronic diseases, improving regulatory guidelines and the launch of new products will provide the necessary impetus for the growth of the pharmaceutical market in Saudi Arabia The Saudi pharmaceutical market is one of the largest markets …

  • OpportunityAnalyzer: Acne Vulgaris – Opportunity Analysis and Forecasts to 2018
    Published: 20-Jun-2014        Price: US $5995 Onwards        Pages: 177
    Despite its considerable patient population, the acne market has been overlooked and remained stagnant for the last decade. There has been a lack of research efforts due to the perception of a poor return on investment for topical treatments, the mainstay of acne therapy. There is an array of treatment options for acne, though with the exception of isotretinoin, most only provide symptomatic relief as opposed to a curative or disease-modifying solution. However, isotretinoin is unable to serve a......
  • Skin Infections – Pipeline Review, H1 2014
    Published: 15-Jun-2014        Price: US $2000 Onwards        Pages: 183
    Global Markets Direct's, ‘Skin Infections Pipeline Review, H1 2014', provides an overview of the Skin Infections's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Skin Infections, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key playe......
  • Chronic Urticaria Or Hives – Pipeline Review, H1 2014
    Published: 15-Jun-2014        Price: US $2000 Onwards        Pages: 70
    Global Markets Direct's, ‘Chronic Urticaria Or Hives Pipeline Review, H1 2014', provides an overview of the Chronic Urticaria Or Hives's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Chronic Urticaria Or Hives, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press re......
  • Seborrhea – Pipeline Review, H1 2014
    Published: 15-Jun-2014        Price: US $2000 Onwards        Pages: 39
    Global Markets Direct's, ‘Seborrhea Pipeline Review, H1 2014', provides an overview of the Seborrhea's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Seborrhea, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the......
  • Warts – Pipeline Review, H1 2014
    Published: 15-Jun-2014        Price: US $2000 Onwards        Pages: 62
    Global Markets Direct's, ‘Warts Pipeline Review, H1 2014', provides an overview of the Warts's therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Warts, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic......
  • Global and Chinese Phenoxy ethanol (CAS 122-99-6) Industry, 2009-2019 Market Research Report
    Published: 14-Jun-2014        Price: US $2400 Onwards        Pages: 150
    Global and Chinese Phenoxy ethanol (CAS 122-99-6) Industry, 2009-2019 Market Research Report is a professional and in-depth market survey on Global and Chinese Phenoxy ethanol (CAS 122-99-6) industry. The report firstly reviews the basic information of Phenoxy ethanol (CAS 122-99-6) including its classification, application and manufacturing technology; The report then explores global and China's top manufacturers of Phenoxy ethanol (CAS 122-99-6) listing their product specification, capacity, p......
  • Global and Chinese Clobetasol Propionate (CAS 25122-46-7) Industry, 2009-2019 Market Research Report
    Published: 14-Jun-2014        Price: US $2400 Onwards        Pages: 150
    Global and Chinese Clobetasol Propionate (CAS 25122-46-7) Industry, 2009-2019 Market Research Report is a professional and in-depth market survey on Global and Chinese Clobetasol Propionate (CAS 25122-46-7) industry. The report firstly reviews the basic information of Clobetasol Propionate (CAS 25122-46-7) including its classification, application and manufacturing technology; The report then explores global and China's top manufacturers of Clobetasol Propionate (CAS 25122-46-7) listing their pr......
  • Frontier Pharma: Psoriasis – Identifying and Commercializing First-in-Class Innovation
    Published: 30-May-2014        Price: US $3500 Onwards        Pages: 77
    GBI Research has released the pharma report: “Frontier Pharma: Psoriasis Identifying and Commercializing First-in-Class Innovation”, which identifies and assesses first-in-class innovation in the psoriasis development pipeline.Over the last decade, a greater understanding of the underlying pathophysiology of psoriasis has increased emphasis on developing immuneomodulating therapies, as opposed to largely symptomatic treatments. This is currently reflected in a competitive market dominate......
  • Global Non-melanoma Skin Cancer Market 2014-2018
    Published: 23-May-2014        Price: US $3000 Onwards        Pages: 119
    Non-melanoma skin cancer is one of the most common types of cancer in the world. It develops in the upper layers of the skin, but not in melanocytes. There are two types of non-melanoma skin cancer: BCC, which starts in the basal cells, and SCC, which starts in the squamous cells. BCC usually develops in the areas such as the head and neck, whereas SCC starts in the face, ears, neck, lips, and backs of the hands. These can also grow in wounds or chronic skin sores. Non-melanoma skin cancer is ca......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs